维普中文期刊产品整合服务
163篇 您的检索式:作者名="Mahler DA"
    题名 作者 年代 出处 被引量
1The measurement of dyspnea,contents interobserver,agreement and physiological correlates of two new clinical indexes显示文摘Mahler DA Weinberg DH Wells CR 1984Chest1984,85,6:1
2Evaluation of clinical methods for rating dysp- nea 显示文摘Mahler DA Wells CK 1988Chest1988,93,3:1
3A long-term evaluation d once-daily inhaled tiotropium in chronic obstructive pulmonary disease 显示文摘Casaburi R Mahler DA Jones PW 2002Eur Respir J2002,19,2:1
4Salmeterol plus theophylline combination therapy in the treatment of COPD 显示文摘ZuWallack RE Mahler DA Reilly D 2001Chest2001,119,6:1
5A long-time evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease 显示文摘Casaburi R Mahler DA Jones PW 2002Eur Respir J2002,19,2:1
6Effectiveness of fluticasone propionate and salmeterol combination delivered via the disk device in the treatment of chronic obstructive pulmonary disease显示文摘Mahler DA Wire P Horstman D 2002Am J Respir Car Med2002,166,8:1
7Evaluation of clinical meth-ods for rating dyspnea显示文摘Mahler DA Wells CK 1988chest1988,93,3:1
8Along-term evaluation of once-daily inhaledtiotropium in chronic obstructive pulmonarydis- ease显示文摘Casaburi R Mahler DA Jones PW 2010Eur Respir J2010,19,:1
9Endogenous opioidsmodify dyspnoea during treadmill exercise in patients with COPD显示文摘Mahler DA Murray JA Waterman LA 2009Eur Respir J2009,33,:1
10Evaluation of clinical methods for rating dyspnea显示文摘Mahler DA Wells CK 1988Chest1988,93,3:1
11Meaningful effect size and patterns of response of the transition dyspnea index显示文摘Wttek TJ Mahler DA 2003J Clin Epidemiol2003,56,3:1
12Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD显示文摘Tashkin DP Donohue JF Mahler DA 2009Respir Med2009,103,4:1
13Evaluation of clinical methods for rating dyspnea显示文摘Mahler DA Wells CK 1988Chest1988,93,3:1
14Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD:a pilot study显示文摘Mahler DA Huang S Tabrizi M 0,,:1
15American College ofChest Physicians consensus statement on the management of dysp-nea in patients with advanced lung or heart disease 显示文摘Mahler DA Selecky PA Harrod CG 2010Chest2010,137,3:1
16Evaluation of clinical methods for rating dyspnea显示文摘Mahler DA Wells CK 1988Chest1988,93,3:1
17Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease显示文摘Mahler DA Wire P Horstman D 2002Am J Respir Crit Care Med2002,166,8:1
18Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus de- vice in the treatment of chronic obstructive pulmonary disease 显示文摘Mahler DA Wire P Horstman D 2002Am J Respir Crit Care Med2002,166,:1
19Effectiveness of fluticasone propionate and salmeterol combination delivered via the diskus device in the treatment of chronic obstructive pulmonary disease显示文摘Mahler DA Wire P Horstman D 2002Am J Respir Crit Care Med2002,166,:1
20American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease 显示文摘Mahler DA Selecky PA Harrod CG 2010Chest2010,137,3:1
返回顶部 每页显示:
共9页 首页 上一页 第1页 下一页 末页 /9 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费